Enteroviruses Manipulate the Unfolded Protein Response through Multifaceted Deregulation of the Ire1-Xbp1 Pathway.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
10 11 2022
Historique:
received: 19 08 2022
revised: 30 10 2022
accepted: 04 11 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Many viruses are known to trigger endoplasmic reticulum (ER) stress in host cells, which in turn can develop a protective unfolded protein response (UPR). Depending on the conditions, the UPR may lead to either cell survival or programmed cell death. One of three UPR branches involves the upregulation of Xbp1 transcription factor caused by the unconventional cytoplasmic splicing of its mRNA. This process is accomplished by the phosphorylated form of the endoribonuclease/protein kinase Ire1/ERN1. Here, we show that the phosphorylation of Ire1 is up-regulated in HeLa cells early in enterovirus infection but down-regulated at later stages. We also find that Ire1 is cleaved in poliovirus- and coxsackievirus-infected HeLa cells 4-6 h after infection. We further show that the Ire1-mediated Xbp1 mRNA splicing is repressed in infected cells in a time-dependent manner. Thus, our results demonstrate the ability of enteroviruses to actively modulate the Ire1-Xbp1 host defensive pathway by inducing phosphorylation and proteolytic cleavage of the ER stress sensor Ire1, as well as down-regulating its splicing activity. Inactivation of Ire1 could be a novel mode of the UPR manipulation employed by viruses to modify the ER stress response in the infected cells.

Identifiants

pubmed: 36366584
pii: v14112486
doi: 10.3390/v14112486
pmc: PMC9699254
pii:
doi:

Substances chimiques

Endoribonucleases EC 3.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1
RNA, Messenger 0
X-Box Binding Protein 1 0
XBP1 protein, human 0
ERN1 protein, human EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Viruses. 2016 Jun 07;8(6):
pubmed: 27338442
J Biol Chem. 2004 Apr 23;279(17):17158-64
pubmed: 14960590
Biochem Biophys Res Commun. 2017 Oct 28;492(4):533-540
pubmed: 28167278
Nat Rev Immunol. 2017 Mar;17(3):151-164
pubmed: 28138137
Viruses. 2019 Feb 01;11(2):
pubmed: 30717233
Viruses. 2019 Dec 21;12(1):
pubmed: 31877732
Front Microbiol. 2014 Jun 18;5:292
pubmed: 24995003
FEMS Microbiol Rev. 2021 Sep 8;45(5):
pubmed: 33765123
Front Cell Infect Microbiol. 2021 Apr 28;11:668034
pubmed: 33996638
J Cell Biol. 2009 Aug 10;186(3):323-31
pubmed: 19651891
Biochem Biophys Res Commun. 2012 Apr 20;420(4):882-7
pubmed: 22469468
Mol Biol. 2021;55(4):507-537
pubmed: 34092811
Front Microbiol. 2014 Aug 19;5:433
pubmed: 25191311
J Gen Virol. 2014 Jan;95(Pt 1):71-79
pubmed: 24114795
Cell Microbiol. 2010 Jun;12(6):796-813
pubmed: 20070307
Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102
pubmed: 22251901
Front Microbiol. 2014 Aug 05;5:388
pubmed: 25140166
Biochemistry (Mosc). 2021 Sep;86(9):1060-1094
pubmed: 34565312
Mol Cell. 2000 Dec;6(6):1355-64
pubmed: 11163209
J Virol. 1993 Aug;67(8):4688-95
pubmed: 8392608
J Virol. 2010 Sep;84(17):8446-59
pubmed: 20554776
Life Sci. 2021 Jan 15;265:118740
pubmed: 33188833
J Gen Virol. 2002 Jul;83(Pt 7):1547-1564
pubmed: 12075073
Trends Cell Biol. 2013 Nov;23(11):547-55
pubmed: 23880584
Cells. 2021 Sep 24;10(10):
pubmed: 34685515
J Virol. 2004 Sep;78(18):10166-77
pubmed: 15331749
Nat Cell Biol. 2011 Mar;13(3):184-90
pubmed: 21364565
Viruses. 2021 Jun 23;13(7):
pubmed: 34201715
Front Plant Sci. 2012 Dec 28;3:293
pubmed: 23293645
Infect Genet Evol. 2013 Mar;14:282-93
pubmed: 23201849
Cell Death Differ. 2001 Feb;8(2):113-26
pubmed: 11313713
J Biol Chem. 2012 Feb 10;287(7):4679-89
pubmed: 22194594
Cell. 2001 Dec 28;107(7):881-91
pubmed: 11779464
Virulence. 2019 Dec;10(1):376-413
pubmed: 30966844
Cell Microbiol. 2017 May;19(5):
pubmed: 28207988
Biomedicines. 2021 Feb 05;9(2):
pubmed: 33562589
Nature. 1999 Jan 21;397(6716):271-4
pubmed: 9930704
PLoS Pathog. 2020 Sep 30;16(9):e1008927
pubmed: 32997711
Cell. 1999 Dec 23;99(7):691-702
pubmed: 10619423
Virus Res. 2013 Dec 26;178(2):471-7
pubmed: 24177270
Rev Med Virol. 2018 Nov;28(6):e2002
pubmed: 30069956
Mol Biol Cell. 2015 Aug 15;26(16):2873-84
pubmed: 26108623
Mol Cell Biol. 2015 Jun;35(12):2186-202
pubmed: 25870107
Elife. 2019 Aug 27;8:
pubmed: 31453810
Biomed Environ Sci. 2018 Dec;31(12):867-875
pubmed: 30636656
Nat Commun. 2020 Apr 24;11(1):1997
pubmed: 32332742
Pathogens. 2022 Apr 28;11(5):
pubmed: 35631043
Mol Cell. 2018 Jan 18;69(2):169-181
pubmed: 29107536

Auteurs

Anna Shishova (A)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.
Institute for Translational Medicine and Biotechnology, First Moscow State Medical University (Sechenov University), 117418 Moscow, Russia.

Ilya Dyugay (I)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.

Ksenia Fominykh (K)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.

Victoria Baryshnikova (V)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.

Alena Dereventsova (A)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.

Yuriy Turchenko (Y)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.

Anna A Slavokhotova (AA)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.

Yury Ivin (Y)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.

Sergey E Dmitriev (SE)

Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.

Anatoly Gmyl (A)

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI "Chumakov FSC R&D IBP RAS"), 108819 Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH